2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 0 | 25.014 | 48.733 | 44.172 | 153.183 | 719.283 | 1.383.666 | 7.767.460 | 26.388.266 | 6.022.728 |
Total Income - EUR | 0 | 25.065 | 49.236 | 46.993 | 154.812 | 726.825 | 1.462.904 | 7.972.236 | 28.446.836 | 7.527.432 |
Total Expenses - EUR | 0 | 5.425 | 22.268 | 44.319 | 291.613 | 793.352 | 1.909.721 | 7.095.694 | 25.213.415 | 8.924.095 |
Gross Profit/Loss - EUR | 0 | 19.639 | 26.968 | 2.674 | -136.801 | -66.527 | -446.817 | 876.543 | 3.233.421 | -1.396.664 |
Net Profit/Loss - EUR | 0 | 18.889 | 26.230 | 2.211 | -138.333 | -73.731 | -454.739 | 741.029 | 2.848.068 | -1.396.664 |
Employees | 0 | 0 | 3 | 3 | 6 | 6 | 0 | 22 | 32 | 21 |
Check the financial reports for the company - Tigermed S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 9.022 | 6.438 | 3.879 | 2.247 | 4.130 | 21.795 | 87.873 | 64.171 | 51.711 |
Current Assets | 67.163 | 3.657 | 37.944 | 42.949 | 275.373 | 215.342 | 735.599 | 7.487.034 | 12.291.185 | 6.522.201 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 67.099 | 155.454 | 145.741 | 121.532 |
Receivables | 0 | 3.662 | 36.156 | 42.773 | 88.600 | 140.394 | 518.720 | 4.861.120 | 9.785.964 | 6.161.015 |
Cash | 67.163 | -5 | 1.788 | 176 | 186.773 | 74.948 | 149.780 | 2.470.460 | 2.359.480 | 239.653 |
Shareholders Funds | -15.096 | 10.803 | 36.923 | 38.673 | 262.640 | 183.773 | -274.450 | 472.665 | 3.322.200 | 1.915.462 |
Social Capital | 112 | 112 | 111 | 274 | 550 | 539 | 529 | 518 | 519 | 518 |
Debts | 82.259 | 1.875 | 8.219 | 8.258 | 22.473 | 52.431 | 1.056.944 | 7.218.591 | 9.163.413 | 4.761.956 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 818 | 352 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7219 - 7219" | |||||||||
CAEN Financial Year |
7219
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Tigermed S.r.l.